Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1586.7000
15.00
(
0.95
%)
NSE
Oct 26, 2026
14:45 PM
46.73% Gain from 52W Low
Volume:
387.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
11 Feb 2026
1586.70
0.95%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1345 | Target met
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
Aurobindo Pharma Ltd. is trading
below its 30 day SMA
of 1675.0
More from Aurobindo Pharma Ltd.
Recommended
Market trades higher, Apollo Micro Systems' net profit climbs 55.7% YoY in Q2
Trendlyne Marketwatch |
26 Oct 2026, 02:05PM
Pre Monday: An optimist surveys the market during earnings season
The Baseline |
24 Oct 2026
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020